echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > API information: new projects, transformation and production

    API information: new projects, transformation and production

    • Last Update: 2018-02-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [chinapharma network Pharmaceutical Engineering] 1 Introduction to the transformation project of part of the production capacity of Laixin factory of North China Pharmaceutical Co., Ltd to produce vitamin B12 Project name: transformation project of part of the production capacity of Laixin factory of North China Pharmaceutical Hebei Huamin Pharmaceutical Co., Ltd Construction unit: North China Pharmaceutical Hebei Huamin Pharmaceutical Co., Ltd Construction site: Laixin factory of North China Pharmaceutical Hebei Huamin Pharmaceutical Co., Ltd is located in the east of Xingye street and the south of Huai'an Road, Shijiazhuang Economic and Technological Development Zone The central coordinates of the plant site are 38 ° 1'21.30 "north latitude, 114 ° 41'6.82" east longitude, North China Pharmaceutical three wastes center, North China Pharmaceutical Aino pharmaceutical, West Xingye street, North Huai'an Road Beida factory of Hebei Huamin Pharmaceutical Co., Ltd Nature of Construction: total investment in reconstruction: the total investment of the project is 9.95 million yuan, and the investment in environmental protection is 750000 yuan, accounting for 7.5% of the total investment Production scale: production scale: annual output of feed additive and conversion liquid into pure vitamin b1210 tons Construction content: in the south area of the fermentation workshop of the existing plant area, the existing production tanks are used to reconstruct the feeding tanks and storage tanks; in the south area of the membrane filtration workshop, the production of vitamin B12 transformation liquid is realized by using the equipment of Weikang, Weida, 7-ACA, the general plant and some newly purchased equipment, and the production of feed additives is realized by using the original d-7-aca production area This project does not belong to the eliminated projects in the national industrial structure adjustment Guidance Catalogue (2011 version) (revised in 2013), nor the eliminated production equipment and products specified in the guidance catalogue for the elimination of backward production process equipment and products in some industrial industries (2010 version) Therefore, the project construction meets the requirements of national industrial policies The project is in line with the national industrial policy, the project site is in line with the overall planning of the Development Zone, the pollution source control measures of the project are reliable and effective, the pollutants can be discharged up to the standard, the solid wastes can be reasonably disposed, the discharged pollutants have little impact on the surrounding environment, and can meet the requirements of the local environmental function zoning The project meets the requirements of cleaner production; the total amount of pollutants discharged meets the requirements of total amount control of pollutants; the vast majority of the public supports the construction of the project, and the project has good economic and social benefits In conclusion, under the conditions of Comprehensively Strengthening Supervision and management, implementing the "three Simultaneities" system of environmental protection and conscientiously implementing various environmental protection measures, the construction of the project is feasible from the perspective of environmental protection 2 The annual output of 600 tons tenofovir project of Anhui Baker United Pharmaceutical Co., Ltd is under construction in Taihe Recently, the 600 tons tenofovir multi-functional automatic chiral synthesis project of Anhui Baker United Pharmaceutical Co., Ltd has officially started construction, with a total investment of 549 million yuan The project has filled the gap in China Tenofovir is the first-line anti-virus drug recommended by who AIDS treatment guidelines, and it is listed as the first-line anti-virus drug free of charge in China The above projects have built three production lines, 420 million yuan for two production lines, two yuan for investment, and 129 million yuan for the project, and the Internet plus (DCS) distributed control system is adopted to realize the international production informatization, automation and remote control After the project is completed, the annual sales can exceed 1 billion yuan, and the annual contribution of profits and taxes can exceed 200 million yuan Anhui Baker United Pharmaceutical Co., Ltd has a strong R & D team and a sound R & D mechanism Since 2011, the company has won the bid in the National Center for Disease Control and HIV / AIDS drug procurement project for six consecutive years, and successfully completed the drug supply task 3 China announced a high "double anti" tax on the import of o-chloro-p-nitroaniline from India China's Ministry of Commerce said on February 12 that it would impose an anti subsidy tax of 166.8% and an anti-dumping tax of 49.9% on the import of o-chloro-p-nitroaniline from India from February 13 On the same day, the Ministry of Commerce announced the final ruling of anti-dumping and countervailing investigation on the import of o-chloro-p-nitroaniline originating in India The ruling held that there were dumping and subsidies on the imported product, and the industry of o-chloro-p-nitroaniline in China suffered substantial damage, and there was a causal relationship between dumping, subsidies and substantial damage, so it was decided to take anti-dumping and anti subsidy measures against the imported o-chloro-p-nitroaniline originating in India According to the ruling, China will impose 21.2% - 166.8% countervailing duty and 31.4% - 49.9% anti-dumping duty on India's imports of o-chloro-p-nitroaniline O-chloro-p-nitroaniline can be used in the production of drugs for schistosomiasis control, as well as dyes and organic pigments According to Chinese statistics, during the investigation period of this case, the import of o-chloro-p-nitroaniline originating in India increased significantly In 2013-2015, it increased by 624 tons Affected by this, the market share of Chinese products fell, the sales volume fell and the wages of workers fell in the same period.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.